Tufts Center for the Evaluation of Value and Risk in Health (CEVR) is proud to announce its inaugural CEVR Cost-Effectiveness Analysis (CEA) Paper of the Year Award.
Health care policy makers are increasingly seeking evidence on the value of health care to inform clinical guidelines and reimbursement decisions. At CEVR we have seen a substantial rise in cost-effectiveness research being produced to meet this need. This award will highlight this important research and promote findings to a broad audience.
We will consider any original, applied CEA in the fields of health and medicine published in 2018 that reports results in terms of incremental cost-per-QALY gained. We will judge articles based on:
- Timeliness and importance
- Methodological quality
- Potential influence on policy or clinical decision making
Editorials, commentaries, letters, point/counter-points, scientific reports, and economic analyses reporting endpoints other than cost-per-QALY will not be considered.
CEVR will accept nominations through January 31, 2019. Anyone – including the authors themselves or any institution, can nominate a paper. CEVR faculty and staff will select five finalists from among these submissions, and our CEA Registry Advisory Board (comprised of individuals from the life sciences industry, payers, academia, and government) will select the winner, which will be announced in June of 2019. The first author of the winning paper will receive an award of $1,000.
To submit an article, or if you have any questions, please email email@example.com by January 31, 2019.